https://podcasts.apple.com/us/podcast/radiolab/id1
Post# of 36536
Worth a listen. We are not out of the woods yet and what I heard in this is that off-target triggers can contribute to strengthening the evolution of the virus. ii-key works by disrupting and replacing the cell with ii-key, so it has a very strong potential to disrupt the virus in a more targeted way without creating the off-target variants. I wonder how we sign up for phase 1 trials, or for a phase 1 booster trial if it is necessary to separate them.